Steve Tobias
Medical · Dallas, TXNPI 1669721973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 32.7% of the total. Reporting peaked in 2022 at $1,104 and has fallen 98.4% since, to $17 in 2024.
Across 119 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$746
- Amarin Pharma, Inc.$372
- Boehringer Ingelheim$224
- GSK$216
- Lilly USA, LLC$133
- Amgen$94
- plus $498 from 15 others
What the payments were for
- Food & beverage$2,283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $746 |
| Amarin Pharma, Inc. | 15 | $372 |
| Boehringer Ingelheim | 10 | $224 |
| GSK | 12 | $216 |
| Lilly USA, LLC | 9 | $133 |
| Amgen | 4 | $94 |
| AstraZeneca | 6 | $90 |
| Gilead | 4 | $75 |
| AbbVie | 3 | $62 |
| Bayer | 3 | $54 |
| Novartis | 2 | $31 |
| Genentech USA, Inc. | 3 | $31 |
| Merck | 2 | $27 |
| Shield Therapeutics Inc | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Viiv Healthcare Company | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Itamar Medical Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,283 in reported general payments places this provider in the 70th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 17 | $131 |
| Atorvastatin Calcium | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.